Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 218

1.

The effects of Tao-Hong-Si-Wu on hepatic necroinflammatory activity and fibrosis in a murine model of chronic liver disease.

Xi S, Shi M, Jiang X, Minuk GY, Cheng Y, Peng Y, Gong Y, Xu Y, Wang X, Yang J, Yue L, Wang Y.

J Ethnopharmacol. 2016 Mar 2;180:28-36. doi: 10.1016/j.jep.2016.01.030. Epub 2016 Jan 20.

PMID:
26802785
2.
3.

The Geographic Distribution of Liver Cancer in Canada Does Not Associate with Cyanobacterial Toxin Exposure.

Labine MA, Green C, Mak G, Xue L, Nowatzki J, Griffith J, Minuk GY.

Int J Environ Res Public Health. 2015 Nov 30;12(12):15143-53. doi: 10.3390/ijerph121214969.

4.

Cancer stem cell invasion of the hepatic microvasculature as a predictor of tumour recurrence following surgical resection in adult patients with hepatocellular carcinoma.

Bautista W, Cuvelier S, Perez-Alvarez V, Uhanova J, Minuk GY, Klein J, Lipschitz J, McKay A.

Can J Gastroenterol Hepatol. 2015 Nov-Dec;29(8):409. Epub 2015 Sep 11. No abstract available.

PMID:
26359626
5.

Factors associated with spontaneous clearance of hepatitis C virus in Chinese population.

Kong F, Pan Y, Chi X, Wang X, Chen L, Lv J, Sun H, Wu R, Jin J, Yu G, Ma Z, Wang Y, Huang X, Li H, Bai Y, Jia J, Minuk GY, Zhong J, Sun B, Jiang J, Niu J.

Biomed Res Int. 2014;2014:527030. doi: 10.1155/2014/527030. Epub 2014 Jul 16.

6.

Long-term, low-dose exposure to microcystin toxin does not increase the risk of liver tumor development or growth in mice.

Labine M, Minuk GY.

Hepatol Res. 2015 Jun;45(6):683-92. doi: 10.1111/hepr.12394. Epub 2014 Aug 27.

PMID:
25052518
7.

Hepatitis B and hepatitis C viral infections in patients with chronic lymphocytic leukemia.

Minuk GY, Lerner B, Gibson SB, Johnston JB, Uhanova J, Andonov A, Wu J.

Can J Gastroenterol Hepatol. 2014 Mar;28(3):131-4.

8.

Baseline Comorbidities Enhance the Risk of Treatment-Induced Depression in HCV-Infected Men: A Pilot Study.

Rempel JD, Krueger C, Minuk GY, Wong SG.

Am J Mens Health. 2014 Sep;8(5):427-33. doi: 10.1177/1557988314521231. Epub 2014 Feb 3.

PMID:
24493076
9.

Treatment of chronic hepatitis C in a Canadian Aboriginal population: results from the PRAIRIE study.

Minuk GY, O'Brien M, Hawkins K, Emokpare D, McHattie J, Harris P, Worobetz L, Doucette K, Kaita K, Wong S, Pinette G, Uhanova J.

Can J Gastroenterol. 2013 Dec;27(12):707-10.

10.

A paucity of liver disease in Canadian Inuit with chronic hepatitis B virus, subgenotype B6 infection.

Minuk GY, Macrury S, Uhanova J, Caouette S, Coleman N, Cummings K, Larke B, Vardy L, Triet Huyn C, Osiowy C.

J Viral Hepat. 2013 Dec;20(12):890-6. doi: 10.1111/jvh.12121. Epub 2013 May 29.

PMID:
24304459
11.

Establishing diagnostic criteria for occult hepatitis B virus infections in community based populations.

Minuk GY, Huynh C, Uhanova J, Osiowy C.

J Med Virol. 2014 Jan;86(1):156-61. doi: 10.1002/jmv.23813. Epub 2013 Oct 16.

PMID:
24132580
12.

Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study.

Holmes S, Griffith EJ, Musto G, Minuk GY.

Cancer Epidemiol. 2013 Dec;37(6):881-5. doi: 10.1016/j.canep.2013.09.001. Epub 2013 Sep 25.

PMID:
24075077
13.

The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.

Zhang M, Wu R, Jiang J, Minuk GY, Niu J.

Alcohol. 2013 Nov;47(7):553-8. doi: 10.1016/j.alcohol.2013.07.003. Epub 2013 Sep 13.

PMID:
24041840
14.

The epidemiology of hepatitis C in a Canadian Indigenous population.

Uhanova J, Tate RB, Tataryn DJ, Minuk GY.

Can J Gastroenterol. 2013 Jun;27(6):336-40.

15.

Genetic diversity of hepatitis B virus genotypes B6, D and F among circumpolar indigenous individuals.

Kowalec K, Minuk GY, Børresen ML, Koch A, McMahon BJ, Simons B, Osiowy C.

J Viral Hepat. 2013 Feb;20(2):122-30. doi: 10.1111/j.1365-2893.2012.01632.x. Epub 2012 Jul 3.

PMID:
23301547
16.

The prevalence and long term outcome of occult hepatitis B virus infections in community based populations.

Minuk GY, Kowalec K, Caouette S, Larke B, Osiowy C.

J Med Virol. 2012 Sep;84(9):1369-75. doi: 10.1002/jmv.23351.

PMID:
22825815
17.

A population-based study of the epidemiology of hepatitis C in a North American population.

Uhanova J, Tate RB, Tataryn DJ, Minuk GY.

J Hepatol. 2012 Oct;57(4):736-42. doi: 10.1016/j.jhep.2012.05.018. Epub 2012 Jun 2.

PMID:
22668641
18.

Extent of extracellular signal-regulated kinases phosphorylation determines the sensitivity of hepatic stellate cells to staurosporine-induced apoptosis.

Fan J, Shen H, Dai Q, Burzynski FJ, Minuk GY, Gong Y.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Jan;37(1):11-6. doi: 10.3969/j.issn.1672-7347.2012.01.003.

19.

Activation of β-adrenergic receptors increases the in vitro migration of malignant hepatocytes.

Lodewyks C, Rodriguez JF, Yan J, Lerner B, Sun D, Rempel JD, Uhanova J, Labine M, Minuk GY.

Hepatol Res. 2011 Oct;41(10):1000-8. doi: 10.1111/j.1872-034X.2011.00854.x.

PMID:
21951873
20.

Liver transplant outcomes in a Canadian First Nations population.

Zhang M, Uhanova J, Minuk GY.

Can J Gastroenterol. 2011 Jun;25(6):307-10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk